Govt wants Serum Institute to lower price of AstraZeneca shot: Report
Premium
(Photo: Mint)
Neha Arora,
, Reuters
Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot
Share Via
Read Full Story
The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's COVID-19 vaccine, people close to the matter said, delaying the roll-out of the country's immunisation programme.
India's drug regulator has approved emergency use of the vaccine developed by Oxford University as well as another developed by Indian firm Bharat Biotech, but the government has not placed firm orders with either firm.